Prevacid Capsule, Delayed Release
Product Images NDC 64764-046

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Prevacid (NDC 64764-046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Prevacid 01)

FDA Label Image

Figure 1 (Prevacid 02)

The text represents a table showing the mean severity of day heartburn by study day for evaluable patients. The table compares the results of three treatments: placebo, Lansoprazole 15 mg, and Lansoprazole 30 mg. The severity of heartburn is measured on a scale of 0 to 3, where 0 represents no heartburn and 3 represents severe heartburn. The study lasted for 60 days.*

FDA Label Image

Figure 2 (Prevacid 03)

This is a chart showing the mean severity of night heartburn for evaluable patients, with a rating scale of 0 (none) to 3 (severe). The chart also shows the percentage of patients who rated their heartburn severity as mild, moderate, or severe over the course of several days of treatment.*

FDA Label Image

Prevacid Lansoprazole Delayed-release Capsules 15 mg Bottle Label (Prevacid 04)

This text is a medication label for Prevacid 15mg Delayed-release Capsules. It is important to not accept the product if the seal is broken, keep it out of reach of children and store it at 25°C. The dosage instructions are located in the package insert and each capsule contains 15mg of lansoprazole (ansoprazole), with the TAP and PREVACID 15 imprinted on them. The product is distributed by Takeda Pharmaceuticals and a medication guide should be provided to each patient.*

FDA Label Image

Prevacid Lansoprazole Delayed-release Capsules 30 mgl Bottle Label (Prevacid 05)

This is a description of a medication called PREVACID 30. The usual dosage and other important instructions can be found in the package insert. The medication comes in pink and black delayed-release capsules, each containing 30mg of lansoprazole that is coated with an enteric coating. It is advised to store the medication at 25°C and keep it out of the reach of children. The NDC number for the product is 64764-046-13, and it is distributed by Takeda Pharmaceuticals America, Inc. There is also a warning not to accept the medication if the bottle opening is broken or missing.*

FDA Label Image

Prevacid Lansoprazole Delayed-release Orally Disintegrating Tablets 15 mg Blister Carton Label (Prevacid 06)

This is a description of a medication item called PREVLID SoluTab. It comes in a box of 100 tablets, and there are 10 packs in each box that contain 10 tablets each. The tablets are orally disintegrating and delayed-release, and contain LANSOPRAZOLE as an active ingredient. The text also includes some numerical data and a barcode.*

FDA Label Image

Prevacid Lansoprazole Delayed-release Orally Disintegrating Tablets 30 mg Blister Carton Label (Prevacid 07)

This is a description of a medication called PREVACID SoluTab. It is a type of Lansoprazole, which comes in 10 packs of 10 tablets each. The tablets are delayed-release orally disintegrating tablets and are available only with a prescription. The text also contains some unclear and unrecognizable characters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.